Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis

PHASE2TerminatedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

May 31, 2016

Study Completion Date

January 1, 2017

Conditions
Allergic Conjunctivitis
Interventions
DRUG

hydrocortisone ophthalmic ointment 0.5%

"* Patients will be instructed to apply Hydrocortisone Ophthalmic Ointment 0.5% or placebo in the lower cul de sac or lid margin BID~* Patients will be instructed to not use the study medications at least 2 hours prior to their appointment.~* Study medication dosing details:~ * 0.05 grams hydrocortisone per gram of combination product~ * each application equal to 1/20th of a gram~ * total amount of active ingredient applied to each eye per application = 0.0025 grams hydrocortisone~ * total amount hydrocortisone applied per eye per day = 0.005 grams hydrocortisone~ * Total amount of active ingredient applied per eye throughout duration of the two week study = 0.07 grams hydrocortisone"

DRUG

placebo

Mineral oil and white petrolatum

Trial Locations (1)

40509

Koffler Vision Group, Lexington

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Fera Pharmaceuticals, LLC

UNKNOWN

lead

Koffler Vision Group

OTHER